串联结肠镜检查腺瘤漏诊率的程度、危险因素及相关因素:系统评价与荟萃分析
该系统评价与荟萃分析纳入截至2018年4月发表的43篇串联结肠镜研究、超过15000次检查,估算腺瘤漏诊率为26%(95%CI 23%-30%),进展期腺瘤漏诊率为9%(95%CI 4%-16%),锯齿状息肉漏诊率为27%(95%CI 16%-40%);充分肠道准备和辅助技术可降低漏诊率,腺瘤检出率、每次指数结肠镜腺瘤数和每次阳性指数结肠镜腺瘤数与腺瘤漏诊率独立相关。
要点
- 腺瘤漏诊率26%,进展期腺瘤漏诊率9%,锯齿状息肉漏诊率27%。
- 近端进展期腺瘤漏诊率14%,平坦腺瘤34%,结直肠癌高危人群33%。
- 充分肠道准备和辅助技术可降低漏诊率(P=.06;P=.04;P=.01)。
核心结论
- 腺瘤和进展期腺瘤的漏诊率高于既往认为的水平。
- 除腺瘤检出率外,每次阳性指数结肠镜腺瘤数值得考虑作为结肠镜检查质量的补充指标,但需在更多研究中验证。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Web of Science和Ovid EMBASE数据库截至2018年4月发表的串联结肠镜研究。
- 纳入43篇文献,超过15000次串联结肠镜检查;主要结局为腺瘤漏诊率和进展期腺瘤漏诊率。
主要发现
- 腺瘤漏诊率26%(95%CI 23%-30%),进展期腺瘤漏诊率9%(95%CI 4%-16%),锯齿状息肉漏诊率27%(95%CI 16%-40%)。
- 近端进展期腺瘤漏诊率14%(95%CI 5%-26%),平坦腺瘤漏诊率34%(95%CI 24%-45%),结直肠癌高危患者漏诊率33%(95%CI 26%-41%)。
- 充分肠道准备和辅助技术可降低漏诊率(P=.06;P=.04;P=.01)。
- 腺瘤检出率、每次指数结肠镜腺瘤数和每次阳性指数结肠镜腺瘤数均与腺瘤漏诊率独立相关(P=.02;P=.01;P=.008),每次阳性指数结肠镜腺瘤数是唯一与进展期腺瘤漏诊率独立相关的因素(P=.006)。
- 每次阳性指数结肠镜腺瘤数>1.8监测腺瘤漏诊率优于腺瘤检出率≥34%(腺瘤漏诊率31% vs 15%,P<.0001;27% vs 17%,P=.008);每次阳性指数结肠镜腺瘤数<1.7的检查进展期腺瘤漏诊率为35%,≥1.7者为2%(P=.0005)。
关键数值与推荐
- 腺瘤漏诊率26%(95%CI 23%-30%),进展期腺瘤漏诊率9%(95%CI 4%-16%)。
- 锯齿状息肉漏诊率27%(95%CI 16%-40%),近端进展期腺瘤漏诊率14%(95%CI 5%-26%),平坦腺瘤漏诊率34%(95%CI 24%-45%)。
- 结直肠癌高危患者漏诊率33%(95%CI 26%-41%)。
- 每次阳性指数结肠镜腺瘤数>1.8时腺瘤漏诊率31% vs 15%(P<.0001),腺瘤检出率≥34%时腺瘤漏诊率27% vs 17%(P=.008)。
- 每次阳性指数结肠镜腺瘤数<1.7时进展期腺瘤漏诊率35%,≥1.7时为2%(P=.0005)。
临床怎么用
- 原文结论认为腺瘤检出率之外,每次阳性指数结肠镜腺瘤数值得考虑作为结肠镜检查质量的补充指标,但需在更多研究中验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We performed a systematic review and meta-analysis to comprehensively estimate adenoma miss rate (AMR) and advanced AMR (AAMR) and explore associated factors. METHODS: We searched the PubMed, Web of Science, and Ovid EMBASE databases for studies published through April 2018 on tandem colonoscopies, with AMR and AAMR as the primary outcomes. We performed meta-regression analyses to identify risk factors and factors associated with outcome. Primary outcomes were AMR and AAMR and secondary outcomes were AMR and AAMR for different locations, sizes, pathologies, morphologies, and populations. RESULTS: In a meta-analysis of 43 publications and more than 15,000 tandem colonoscopies, we calculated miss rates of 26% for adenomas (95% confidence interval [CI] 23%-30%), 9% for advanced adenomas (95% CI 4%-16%), and 27% for serrated polyps (95% CI 16%-40%). Miss rates were high for proximal advanced adenomas (14%; 95% CI 5%-26%), serrated polyps (27%; 95% CI 16%-40%), flat adenomas (34%; 95% CI 24%-45%), and in patients at high risk for colorectal cancer (33%; 95% CI 26%-41%). Miss rates could be decreased by adequate bowel preparation and auxiliary techniques (P = .06; P = .04, and P = .01, respectively). The adenoma detection rate (ADR), adenomas per index colonoscopy, and adenomas per positive index colonoscopy (APPC) were independently associated with AMR (P = .02, P = .01, and P = .008, respectively), whereas APPC was the only factor independently associated with AAMR (P = .006). An APPC value greater than 1.8 was more effective in monitoring AMR (31% vs 15% for AMR P < .0001) than an ADR value of at least 34% (27% vs 17% for AMR; P = .008). The AAMR of colonoscopies with an APPC value below 1.7 was 35%, vs 2% for colonoscopies with an APPC value of at least 1.7 (P = .0005). CONCLUSIONS: In a systematic review and meta-analysis, we found that adenomas and advanced adenomas are missed (based on AMR and AAMR) more frequently than previously believed. In addition to ADR, APPC deserves consideration as a complementary indicator of colonoscopy quality, if it is validated in additional studies.
引用
- Zhao S, Wang S, Pan P, et al. Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. Gastroenterology. 2019. PMID: 30738046. doi:10.1053/j.gastro.2019.01.260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。